Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) just unveiled an announcement.
Shandong Boan Biotechnology Co., Ltd. has announced proposed amendments to its Articles of Association following the completion of a share placement. The amendments reflect changes in the company’s capital structure, increasing the total number of ordinary shares to 574,333,694, all of which are H shares, and adjusting the registered capital to RMB574,333,694. These changes align with the company’s strategic objectives and provide a framework for future growth and shareholder value enhancement.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the biotechnology industry. The company focuses on the development and commercialization of biopharmaceutical products, with a market emphasis on innovative therapies and biotechnology solutions.
Average Trading Volume: 16,854,459
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$7.14B
See more insights into 6955 stock on TipRanks’ Stock Analysis page.